Top 21 Amphivena Therapeutics investors
The most complete profiles first. Showing 21 of 21.
Brian GoodmanVerified
Venture Capital, Private Equity Firm, Investment Partner · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Daniel OmsteadVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Priothera, Sutro Biopharma, Therachon, Caribou Biosciences and 26 more
Verified email available
Dries ColpaertVerified
Family Investment Office · Belgium
Health CareTelecommunicationsInvestment ManagementAndroidPortfolio: ProDigest, Greenbyte AB, SET Ventures, reMYND and 19 more
Verified email available
Frederik BauwensVerified
Family Investment Office · Belgium
Health CareTelecommunicationsInvestment ManagementAndroidPortfolio: ProDigest, Greenbyte AB, SET Ventures, reMYND and 19 more
Contact details available
Luke EvninVerified
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Shinichiro FuseVerified
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Todd FoleyVerified
Venture Capital, Private Equity Firm, Investment Partner · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Vincent VlieberghVerified
Family Investment Office · Belgium
Health CareTelecommunicationsIntelligent SystemsEnergyPortfolio: ProDigest, Greenbyte AB, SET Ventures, reMYND and 19 more
Verified email available
Ed Hurwitz
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, Protego Biopharma, InformedDNA, Mitobridge and 60 more
Contact details available
Stephen Curtis
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
Brieuc de Hults
Family Investment Office · Belgium
Health CareTelecommunicationsInvestment ManagementAndroidPortfolio: ProDigest, Greenbyte AB, SET Ventures, reMYND and 19 more
Contact details available
Christiana Bardon M.D.
Venture Capital, Private Equity Firm, Investment Partner · United States
Health CareGeneticsInvestment ManagementLife SciencePortfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
Gert Ryckmans, CFA
Family Investment Office · Belgium
Health CareTelecommunicationsInvestment ManagementAndroidPortfolio: ProDigest, Greenbyte AB, SET Ventures, reMYND and 19 more
Contact details available
Jason Akus
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Priothera, Sutro Biopharma, Therachon, Caribou Biosciences and 26 more
Contact details available
Jérôme Thomas, CFA
Family Investment Office · Belgium
Health CareTelecommunicationsInvestment ManagementAndroidPortfolio: ProDigest, Greenbyte AB, SET Ventures, reMYND and 19 more
Contact details available
Laure Hilbert
Family Investment Office · Belgium
Health CareTelecommunicationsIntelligent SystemsEnergyPortfolio: ProDigest, Greenbyte AB, SET Ventures, reMYND and 19 more
Contact details available
Leigh Zawel
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
Pablo Queriat, PhD
Family Investment Office · Belgium
Health CareTelecommunicationsInvestment ManagementAndroidPortfolio: ProDigest, Greenbyte AB, SET Ventures, reMYND and 19 more
Contact details available
Thomas De Kempeneer
Family Investment Office · Belgium
Health CareTelecommunicationsIntelligent SystemsEnergyPortfolio: ProDigest, Greenbyte AB, SET Ventures, reMYND and 19 more
Contact details available
Vinay Bhaskar
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
Franklin Berger
Angel/Individual, Investment Partner · United States
Health CareBiotechnologyTherapeuticsPortfolio: Auron Therapeutics, Amphivena Therapeutics
Contact details available
By investment stage
- Seed2
By location
Related industries
Most-backed portfolio companies
- TCR29
- Sensorfact9
- BioIntervene9
- Planet-eco9
- IOmx Therapeutics9
- Eneida9
- Theraclone Sciences9
- InformedDNA9
- VoltStorage9
- Blade Therapeutics9
- Voltalia9
Frequently asked questions
How many Amphivena Therapeutics investors are on Angel Roster?
Angel Roster lists 21 Amphivena Therapeutics investors. 7 of them (33%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (11), Private Equity Firms (9) and Family Offices (9). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Amphivena Therapeutics investors invest in?
Among those that list a stage, the most common are Seed (2).
Where are Amphivena Therapeutics investors based?
Most are based in the United States (12) and Belgium (9).
Which companies have Amphivena Therapeutics investors backed?
The most-backed portfolio companies among them are TCR2 (9), Sensorfact (9), BioIntervene (9), Planet-eco (9) and IOmx Therapeutics (9).
How do I contact Amphivena Therapeutics investors?
Create a free Angel Roster account to search and filter all 21, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.